SHMT2 and neuroblastoma: MYCN can also drive transcription of ATF4 in neuroblastoma cells, and it was demostrated that targeting either MYCN or ATF4 leads to decreased expression levels of PHGDH, PSAT1, SHMT2, MTHFD2, and MTHFD1L (61).